Loading interface...

Darilong 15 Tablet

Manufactured bySUN PHARMA LABORATORIES LTD
ContainsDarifenacin
Description

Darilong 15 Tablet is used for the treatment of an overactive bladder, a condition characterized by symptoms such as a frequent feeling of a need to urinate, sudden urge to urinate, inability to control urination, leaking of urine, etc. This medicine is not recommended for use in patients less than 18 years of age.

Side effects

Major & minor side effects for Darilong 15 Tablet

  • Dry mouth
  • Constipation
  • Dry eyes
  • Nausea and Vomiting
  • Abdominal pain
  • Dry skin
  • Cough
  • Nasal dryness
  • Weight gain
  • Headache
  • Dizziness
  • Back pain

Uses of Darilong 15 Tablet

What is it prescribed for?

  • Overactive Bladder
Read More
Concerns

Commonly asked questions

  • How long does it take for this medicine to take effect?
    The amount of time required for this medicine to show its action is not clinically established.
  • How long do the effects of this medicine last?
    The amount of time for which this medicine remains active in the body is not clinically established.
  • Is it safe to consume alcohol while taking this medicine?
    Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.
  • Is this a habit forming medicine?
    No habit forming tendency has been reported.
  • Can this medicine be taken during pregnancy?
    This medicine is not recommended for use in pregnant women unless necessary. All the risks and benefits should be discussed with the doctor before taking this medicine.
  • Can this medicine be taken while breast-feeding?
    This medicine is not recommended for use in breastfeeding women unless necessary. All the risks and benefits should be discussed with the doctor before taking this medicine. If the medicine is used, close monitoring of the infant for any undesired side effects is recommended.

Allergy

This medicine is not recommended for use in patients with a known allergy to darifenacin or any other inactive ingredients present along with the formulation.

Severe liver impairment

This medicine is not recommended for use in patients suffering from severe liver function impairment due to the increased risk of worsening of the patient's condition.

Urinary retention

This medicine is not recommended for use in patients suffering from urinary retention, a condition where the patient is unable to completely or partially empty the bladder, since it may worsen the patient's condition.

Narrow angle glaucoma

This medicine is not recommended for use in patients suffering from uncontrolled narrow-angle glaucoma due to the increased risk of worsening of the patient's condition.

Gastric retention

This medicine is not recommended for use in patients suffering from gastric retention due to the increased risk of worsening of the patient's condition.

Myasthenia gravis

This medicine is not recommended for use in patients suffering from myasthenia gravis (a neuromuscular disease that leads to weakness of muscles under voluntary control) due to the increased risk of worsening of the patient's condition.

Severe ulcerative colitis

This medicine is not recommended for use in patients suffering from severe ulcerative colitis due to the increased risk of worsening of the patient's condition.
Warnings for special population

Pregnancy

This medicine is not recommended for use in pregnant women unless necessary. All the risks and benefits should be discussed with the doctor before taking this medicine.

Breast-feeding

This medicine is not recommended for use in breastfeeding women unless necessary. All the risks and benefits should be discussed with the doctor before taking this medicine. If the medicine is used, close monitoring of the infant for any undesired side effects is recommended.
General warnings

Angioedema and anaphylactic reactions

This medicine may cause angioedema (swelling) of the face, lips, tongue, etc. as well as severe allergic reactions in some patients. Seek immediate medical intervention if any such reactions develop. Appropriate patient/caregiver counseling, corrective measures, dose adjustments, or replacement with a suitable alternative may be necessary based on the clinical condition.

Liver impairment

This medicine should be used with caution in patients suffering from a mild-to-moderate liver function impairment due to the increased risk of severe adverse effects. Close monitoring of liver function is recommended for such patients. This medicine is not recommended for use in patients with severe liver function impairment. Appropriate dose adjustments or replacement with a suitable alternative may be necessary based on the clinical condition.

Use in children

This medicine is not recommended for use in patients less than 18 years of age since the safety and efficacy of use are not clinically established.

Central nervous system effects

This medicine may cause central nervous system side effects such as a headache, confusion, hallucinations, sleepiness, etc. in some patients. It is advised that you do not perform any activities such as driving a vehicle or operating machinery if you experience any such symptoms during treatment with this medicine. Appropriate corrective measures, dose adjustments, or replacement with a suitable alternative may be necessary based on the clinical condition.

Driving or operating machinery

The use of this medicine may cause symptoms such as dizziness, drowsiness, blurred vision, etc. in some patients. If you experience any such symptoms after taking this medicine, it is advised that you do not perform any activities such as driving a vehicle or operating machinery.

Missed Dose

If a dose of this medicine is missed, take it as soon as you remember. If it is almost time for the next dose, skip the missed dose. Do not double the dose to make up for the missed one.

Overdose

Seek emergency medical treatment or contact the doctor in case of an overdose.
All drugs interact differently for person to person. You should check all the possible interactions with your doctor before starting any medicine.
Interaction with Alcohol

Description

Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.

Instructions

Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.
Interaction with Medicine

Atazanavir

Loxapine

Celecoxib

Clotrimazole

Itraconazole

Disease interactions

Disease

Information not available.
Food interactions
Information not available.
Lab interactions
Information not available.
Take this medicine exactly as instructed by the doctor. Do not take in larger or smaller amounts than prescribed. Seek emergency medical treatment in case of any severe adverse effects. Ensure that the course of treatment is completed. Do not stop the use of this medicine without consulting your doctor.
Miscelleneous

Can be taken with or without food, as advised by your doctor

To be taken as instructed by doctor

May cause sleepiness

How it works
This medicine relaxes the muscles of the urinary bladder; this helps the bladder to retain a larger amount of urine and prevents the symptoms of an overactive bladder.
Legal Status

Approved

Approved

Unknown

Unknown

Classification

Category

Urinary antispasmodics

Schedule

Schedule H

Darifenacin - DrugBank [Internet]. Drugbank.ca. 2020 [cited 22 June 2020]. Available from:

https://www.drugbank.ca/drugs/DB00496

Darifenacin: MedlinePlus Drug Information [Internet]. Medlineplus.gov. 2020 [cited 22 June 2020]. Available from:

https://medlineplus.gov/druginfo/meds/a605039.html

Darifenacin [Internet]. Pubchem.ncbi.nlm.nih.gov. 2020 [cited 22 June 2020]. Available from:

https://pubchem.ncbi.nlm.nih.gov/compound/Darifenacin

DailyMed - Darifenacin Hydrobromide Extended-Release - darifenacin hydrobromide tablet, extended release [Internet]. Dailymed.nlm.nih.gov. 2020 [cited 22 June 2020]. Available from:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=74921ebb-c5e8-4ae3-9ef5-33c15d6522ac

[Internet]. Pdf.hres.ca. 2020 [cited 22 June 2020]. Available from:

https://pdf.hres.ca/dpd_pm/00020092.PDF
Loading related questions...
Something doesn’t feel right?
Report an error

Information on this page was last updated on 27 Jun 2020

Disclaimer

We’ve made all possible efforts to ensure that the information provided here is accurate, up-to-date and complete, however, it should not be treated as a substitute for professional medical advice, diagnosis or treatment. Practo only provides reference source for common information on medicines and does not guarantee its accuracy or exhaustiveness. The absence of a warning for any drug or combination thereof, should not be assumed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Practo does not assume any responsibility for any aspect of healthcare administered with the aid of information provided above. If you have any doubts about your medication then we strongly recommend that you consult with your doctor, nurse or healthcare provider. See detailed T&C here.